Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.

Doolittle ND, Korfel A, Lubow MA, Schorb E, Schlegel U, Rogowski S, Fu R, Dósa E, Illerhaus G, Kraemer DF, Muldoon LL, Calabrese P, Hedrick N, Tyson RM, Jahnke K, Maron LM, Butler RW, Neuwelt EA.

Neurology. 2013 Jul 2;81(1):84-92. doi: 10.1212/WNL.0b013e318297eeba. Epub 2013 May 17.

2.

Cognitive functions in primary CNS lymphoma after single or combined modality regimens.

Correa DD, Shi W, Abrey LE, Deangelis LM, Omuro AM, Deutsch MB, Thaler HT.

Neuro Oncol. 2012 Jan;14(1):101-8. doi: 10.1093/neuonc/nor186. Epub 2011 Oct 19.

3.

Cognitive functions in survivors of primary central nervous system lymphoma.

Correa DD, DeAngelis LM, Shi W, Thaler H, Glass A, Abrey LE.

Neurology. 2004 Feb 24;62(4):548-55.

PMID:
14981169
4.

Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.

Fliessbach K, Helmstaedter C, Urbach H, Althaus A, Pels H, Linnebank M, Juergens A, Glasmacher A, Schmidt-Wolf IG, Klockgether T, Schlegel U.

Neurology. 2005 Apr 12;64(7):1184-8.

PMID:
15824344
5.

Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.

Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T, Fukushima T.

J Neurooncol. 2003 May;63(1):87-95.

PMID:
12814260
6.

Cognitive status and quality of life after treatment for primary CNS lymphoma.

Harder H, Holtel H, Bromberg JE, Poortmans P, Haaxma-Reiche H, Kluin-Nelemans HC, Menten J, van den Bent MJ.

Neurology. 2004 Feb 24;62(4):544-7.

PMID:
14981168
7.

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.

Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, Abrey LE, DeAngelis LM, Omuro A.

J Clin Oncol. 2013 Nov 1;31(31):3971-9. doi: 10.1200/JCO.2013.50.4910. Epub 2013 Oct 7.

8.

Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?

Omuro A, Taillandier L, Chinot O, Sierra Del Rio M, Carnin C, Barrie M, Soussain C, Tanguy ML, Choquet S, Leblond V, Hoang-Xuan K; ANOCEF Group (French Neuro-Oncology Association).

J Neurooncol. 2011 Aug;104(1):323-30. doi: 10.1007/s11060-010-0497-x. Epub 2010 Dec 19.

PMID:
21170569
9.

Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy.

Correa DD, Rocco-Donovan M, DeAngelis LM, Dolgoff-Kaspar R, Iwamoto F, Yahalom J, Abrey LE.

J Neurooncol. 2009 Feb;91(3):315-21. doi: 10.1007/s11060-008-9716-0. Epub 2008 Nov 1.

PMID:
18974934
10.

Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma.

Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS.

J Clin Oncol. 2005 Mar 1;23(7):1507-13.

11.

Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II study.

Kiefer T, Hirt C, Späth C, Schüler F, Al-Ali HK, Wolf HH, Herbst R, Maschmeyer G, Helke K, Kessler C, Niederwieser D, Busemann C, Schroeder H, Vogelgesang S, Kirsch M, Montemurro M, Krüger WH, Dölken G; Ostdeutsche Studiengruppe Hämatologie und Onkologie.

Ann Oncol. 2012 Jul;23(7):1809-12. doi: 10.1093/annonc/mdr553. Epub 2011 Nov 24.

12.

[Management of primary central nervous system lymphoma].

Gonzalez-Aguilar A, Houillier C, Soussain C, Hoang-Xuan K.

Rev Neurol (Paris). 2011 Oct;167(10):721-8. doi: 10.1016/j.neurol.2011.08.004. Epub 2011 Sep 8. Review. French.

PMID:
21906768
13.

Current status and future of relapsed primary central nervous system lymphoma (PCNSL).

Tyson RM, Siegal T, Doolittle ND, Lacy C, Kraemer DF, Neutwelt EA.

Leuk Lymphoma. 2003 Apr;44(4):627-33.

PMID:
12769339
14.

Current management of primary central nervous system lymphoma.

Schultz CJ, Bovi J.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):666-78. doi: 10.1016/j.ijrobp.2009.10.011. Review.

PMID:
20159361
15.

Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.

Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE.

Cancer. 2008 Sep 1;113(5):1025-31. doi: 10.1002/cncr.23670.

16.

[Primary central nervous system lymphoma--a report of 32 cases with literature review].

Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ.

Ai Zheng. 2006 Apr;25(4):476-80. Review. Chinese.

PMID:
16613684
17.

Primary CNS lymphoma.

Batchelor T, Loeffler JS.

J Clin Oncol. 2006 Mar 10;24(8):1281-8. Review.

PMID:
16525183
18.

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.

Cheng T, Forsyth P, Chaudhry A, Morris D, Glück S, Russell JA, Stewart DA.

Bone Marrow Transplant. 2003 Apr;31(8):679-85.

PMID:
12692608
19.

Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.

Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD.

Cancer. 2003 Sep 1;98(5):1021-8.

20.

Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.

Korfel A, Thiel E, Martus P, Möhle R, Griesinger F, Rauch M, Röth A, Hertenstein B, Fischer T, Hundsberger T, Mergenthaler HG, Junghanß C, Birnbaum T, Fischer L, Jahnke K, Herrlinger U, Roth P, Bamberg M, Pietsch T, Weller M.

Neurology. 2015 Mar 24;84(12):1242-8. doi: 10.1212/WNL.0000000000001395. Epub 2015 Feb 25.

PMID:
25716362
Items per page

Supplemental Content

Write to the Help Desk